Navigation Links
ONSOLIS to Benefit from Approval of Class-Wide REMS for All Transmucosal Fentanyl Products
Date:12/29/2011

onal steps required by healthcare providers and their patients."   

Dr. Sirgo continued, "We are very pleased to see the approval of a class-wide REMS program, which we believe will not only mean a level competitive environment, but also the potential for expanded access to ONSOLIS through availability in retail pharmacies.  With the implementation of a class-wide REMS program late in the first quarter of 2012 by Meda Pharmaceuticals, ONSOLIS can finally compete on its own merits."

Healthcare professionals and patients with active enrollment in the ONSOLIS REMS Program (referred to as the FOCUS Program) will be automatically transferred into the new TIRF REMS Access Program.  Additionally, prescribers and patients enrolled in other individual REMS programs will also automatically be transferred into the program.  In addition to consistency in educational materials, technological advances will simplify the process of participation and verification of program participation.  The full program is expected to be implemented in March 2012.

About BioDelivery Sciences International

BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics.  BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and oncology supportive care.  BDSI's pain franchise currently consists of two products utilizing the patented BEMA technology.  ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada, and the E.U. (where it will be marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer.  T
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada
2. BioDelivery Sciences Provides Update on Status of Modified REMS Program for ONSOLIS
3. IQWIG Publishes Early Benefit Assessment for Pirfenidone
4. Texas to Modernize Medicaid Rx Benefits, Curb Pharmacy Overpayments
5. Bayers Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies
6. Breast Cancer Vaccine Reduces Cancer Recurrence in Women: Interim Results From Phase 2 Clinical Trial Trend Toward AE37 Vaccine Benefit; Results Presented at SABCS
7. Survival Benefit With Syndax Pharmaceuticals Entinostat Maintained in Women with Advanced Breast Cancer
8. New Consumer Survey Finds Overwhelming Satisfaction with Pharmacy Benefits
9. Linking EudraCT and ClinicalTrials.gov Records Provides Huge Benefit
10. AMCP Urges HHS to Allow Flexibility in the Design of Prescription Drug Benefits Under Health Care Reform Law
11. Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcanos Precision Guided Therapy Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Ardelyx, Inc. (NASDAQ: ARDX ... gastrointestinal, and metabolic diseases, today announced that a ... Stage 3 chronic kidney disease patients with type ... the primary endpoint of decreasing the urinary albumin-creatinine ... placebo. Ardelyx formed a partnership ...
(Date:5/5/2015)... , May 5, 2015 /CNW Telbec/ - ... Laval and known under the « ... the closing of the transaction previously announced on April ... issued and outstanding  shares of Orthoconcept (2008) inc.   ... 500 000 common shares (TSXV: ERG) to the vending ...
(Date:5/5/2015)... -- The preclinical contract research organization Absorption Systems , ... safety testing of medical devices, announces that Dr. ... at this week,s annual meeting of The Association for ... Denver, CO. The title of Dr. Gum,s ... Bio-Absorbable Carboxymethyl Hyaluronic Acid (CMHA) Polymer in a Rabbit ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3
... The U.S. Food and Drug Administration today approved Kalydeco ... fibrosis (CF) in patients ages 6 years and older who ... Regulator (CFTR) gene. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... lungs and other organs that ultimately leads to an early ...
... (OTCBB: VYST), the exclusive creator of Vytex® Natural Rubber ... first Chinese patent for its all-natural raw material. The company ... US and abroad that relate to Vytex NRL, with more ... ) The new US patent expands the claims ...
Cached Medicine Technology:FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis 2FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis 3Vystar® Corporation Receives its Third US Patent and First Chinese Patent for Vytex® Natural Rubber Latex 2Vystar® Corporation Receives its Third US Patent and First Chinese Patent for Vytex® Natural Rubber Latex 3
(Date:5/5/2015)... 05, 2015 “Given that Hispanics are one ... the CDC report are a major step in the arsenal ... everyone. For the past 30 years, data have accumulated that ... Today we see the urgency and the need to create ... health outcomes for all,” said Jane L. Delgado, PhD, MS, ...
(Date:5/5/2015)... 2015 The global lab automation market ... $3,474.2 Million in 2014, at an estimated CAGR of ... lab automation market on the basis of equipment and ... On the basis of application, Lab Automation Market is ... proteomics solutions. Drug discovery is a major application of ...
(Date:5/5/2015)... The newly minted Regan Arts has just released a unique self-help ... from his 20 years working in the field of wilderness therapy. ... a parenting book and why this one, she replied, “What resonates ... it is a journey, not a destination...that the question is not ... together and sometimes not...that each of our struggles is unique. What ...
(Date:5/5/2015)... Georgia (PRWEB) May 05, 2015 ... of Victoria BC announced the Skedans Sensor Collaboration ... platform, for mobile and web app developers, provides tooling ... airborne and mobile sensors. , The Skedans Sensor Collaboration ... the intersection of the Internet of Things, Web Real ...
(Date:5/5/2015)... Information Innovators Inc. ... federal government, today announced its acquisition of ... solutions exclusively to federal government customers through its ... security, health services, and program management support. The ... as a Third Party Assessment Organization (3PAO) for ...
Breaking Medicine News(10 mins):Health News:“Its about time,” Declares the National Alliance for Hispanic Health on First CDC Study of Hispanic Health 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4
... make you less upset about making errors, according to ... a journal of the Association for Psychological Science. The ... distress-response while participants made mistakes on a test. Those ... less prominent response to mistakes than those who hadn,t. ...
... them to investigate, for the first time, how human testes ... Until now it has been impossible to study testicular development ... to understand the processes that can lead to the onset ... and how factors, such as common environmental chemicals, might play ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... As of 2009, almost 3 in every 10 adults ... in 2007, according to a new government report released Tuesday. ... Disease Control and Prevention (CDC), also found that between 2007-2009, ...
... Project, joined by major consumer, physician and chemical manufacturer ... would give the U.S. Food and Drug Administration (FDA) ... organizations made the announcement in a joint letter to ... Michael Bennet (D-CO), who will introduce this drug safety ...
... all-over tan may be impossible to achieve because some body ... study has found. Researchers - funded by the Medical ... the results explain why some holidaymakers find it so hard ... The findings, published in the journal Experimental Dermatology , ...
... big impact on the food you eat, the clothes you ... in a special section on Culture and Psychology in ... for Psychological Science, psychological scientists Denise C. Park from the ... University of Illinois at Urbana-Champaign discuss ways in which brain ...
Cached Medicine News:Health News:Brain study shows that thinking about God reduces distress -- but only for believers 2Health News:Scientists develop the first model for investigating the origins of testicular cancer in humans 2Health News:Number of Obese Adults Keeps Rising, CDC Says 2Health News:Number of Obese Adults Keeps Rising, CDC Says 3Health News:Consumer and manufacturing groups back bill to protect US drug supply 2Health News:Consumer and manufacturing groups back bill to protect US drug supply 3Health News:All-over tan is a myth, study finds 2Health News:Culture wires the brain: A cognitive neuroscience perspective 2
Superior Skin Care...FlexWear skin barrier provides skin protection for an extended wear time....
Protects skin from corrosive drainage with the standard wear, FlexWear skin barrier. Convenient: accommodates stomas up to 102 mm; wide bottom opening permits hand access; attached pouch closure....
FlexWear is a cross-linked hydrocolloid skin barrier that provides aggressive adherence and is designed for more than one day weartime....
Inquire...
Medicine Products: